AKTS stock news
This page provides real-time market news, earnings updates, and company announcements related to Aktis Oncology, Inc. (AKTS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-16 23:41 EST
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
Finviz2026-02-24 13:03:09
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
Finviz2026-02-24 13:03:09
Aktis Oncology to Present at Upcoming March Investor Conferences
Finviz2026-02-24 21:09:41
Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results
Finviz2026-03-30 20:06:12
AKTS stock chart
AKTS stock detailsAKTS stock price change
On the last trading day, AKTS stock closed at 18.09 USD, with a price change of 1.40% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more